Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Tung

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Survey of Ophthalmology|March 5, 2011
The man who could not see what he could not eatJonathan D Tung, Sang-Rog Oh, Allen B Gruber, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2000
Novel inhibitors of HIV protease: design, synthesis and biological evaluation of picomolar inhibitors containing cyclic P1/P2 scaffoldsA Spaltenstein, M R Almond, W J Bock, et al.
Journal of Medicinal Chemistry|October 16, 1992
Development of a novel class of cyclic hexapeptide oxytocin antagonists based on a natural productP D Williams, M G Bock, R D Tung, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1991
In vitro pharmacological profile of a novel structural class of oxytocin antagonistsD J Pettibone, B V Clineschmidt, E V Lis, et al.
Scandinavian Journal of Gastroenterology|March 1, 2003
Prevalence and clinical implications of hepatitis B virus genotypes in southern TaiwanC M Lee, C H Chen, S N Lu, et al.
Journal of Viral Hepatitis|March 5, 2003
Mutations in the NS5A and E2-PePHD region of hepatitis C virus type 1b and correlation with the response to combination therapy with interferon and ribavirinC-H Hung, C-M Lee, S-N Lu, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 1999
Design, synthesis, and conformational analysis of a novel series of HIV protease inhibitorsC T Baker, F G Salituro, J J Court, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 15, 2017
Altering Metabolic Profiles of Drugs by Precision Deuteration 2: Discovery of a Deuterated Analog of Ivacaftor with Differentiated Pharmacokinetics for Clinical DevelopmentScott L Harbeson, Adam J Morgan, Julie F Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 1998
Streptococcal cell wall-induced arthritis: requirements for IL-4, IL-10, IFN-gamma, and monocyte chemoattractant protein-1R C Schimmer, D J Schrier, C M Flory, et al.
Scientific Reports|August 12, 2017
Assessing cell-nanoparticle interactions by high content imaging of biocompatible iron oxide nanoparticles as potential contrast agents for magnetic resonance imagingRoxanne Hachani, Martin A Birchall, Mark W Lowdell, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Survey of Ophthalmology|March 5, 2011
The man who could not see what he could not eatJonathan D Tung, Sang-Rog Oh, Allen B Gruber, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2000
Novel inhibitors of HIV protease: design, synthesis and biological evaluation of picomolar inhibitors containing cyclic P1/P2 scaffoldsA Spaltenstein, M R Almond, W J Bock, et al.
Journal of Medicinal Chemistry|October 16, 1992
Development of a novel class of cyclic hexapeptide oxytocin antagonists based on a natural productP D Williams, M G Bock, R D Tung, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1991
In vitro pharmacological profile of a novel structural class of oxytocin antagonistsD J Pettibone, B V Clineschmidt, E V Lis, et al.
Scandinavian Journal of Gastroenterology|March 1, 2003
Prevalence and clinical implications of hepatitis B virus genotypes in southern TaiwanC M Lee, C H Chen, S N Lu, et al.
Journal of Viral Hepatitis|March 5, 2003
Mutations in the NS5A and E2-PePHD region of hepatitis C virus type 1b and correlation with the response to combination therapy with interferon and ribavirinC-H Hung, C-M Lee, S-N Lu, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 1999
Design, synthesis, and conformational analysis of a novel series of HIV protease inhibitorsC T Baker, F G Salituro, J J Court, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 15, 2017
Altering Metabolic Profiles of Drugs by Precision Deuteration 2: Discovery of a Deuterated Analog of Ivacaftor with Differentiated Pharmacokinetics for Clinical DevelopmentScott L Harbeson, Adam J Morgan, Julie F Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 1998
Streptococcal cell wall-induced arthritis: requirements for IL-4, IL-10, IFN-gamma, and monocyte chemoattractant protein-1R C Schimmer, D J Schrier, C M Flory, et al.
Scientific Reports|August 12, 2017
Assessing cell-nanoparticle interactions by high content imaging of biocompatible iron oxide nanoparticles as potential contrast agents for magnetic resonance imagingRoxanne Hachani, Martin A Birchall, Mark W Lowdell, et al.
Pageof 6